SUBSCribe
logo
twitterlinkedininstagramUser Profile
search
  • BIG STORY
  • PERSPECTIVE
    • Editor's Note
  • ENTERPRISE
    • STRATEGY
      • HIGH FIVE
      • AD Break
    • MARKETS
      • PIXTORY
        • SPECIALS
        • VIDEOS
        • Spotlight Initiatives
        • C’est La Vie
          • My Favourite
          • Pursuit of Happiness
          • The Good Life
          • Hardbound
        • MAGAZINE
        • EVENTS
        • Bhavin Shah

          Sameeksha Capital's founder is impressed by PSP Projects’ execution and capital efficiency

          December 14, 2017
        • Nursing Back to Health

          A strong product pipeline and receding US FDA threat could well turn the tide in favour of the beleaguered pharma players

          Jash Kriplani - October 18, 2017
        • Sankaran Naren

          How the price of uncertainty threw up a great bargain in the form of Cadila Healthcare and how his relative bet on NTPC didn’t work out

          Khushboo Balani - September 19, 2017
        • One giant leap for Mankind

          Mankind Pharma made it big in small towns, but can its magic help it conquer the bigger markets?

          Himanshu Kakkar - January 21, 2016
        • Not all is well

          Well-positioned niche products that led to robust growth have now started to lose steam

          Krishna Gopalan - December 12, 2015

        Latest Edition

        magcover
        June 01, 2023
        magcover
        May 01, 2023
        magcover
        April 01, 2023
        magcover
        March 01, 2023
        twitterlinkedininstagramUser Profile
        • BIG STORY
        • PERSPECTIVE
        • ENTERPRISE
        • STRATEGY
        • MARKETS
        • PIXTORY
        • SPECIALS
        • VIDEOS
        • WOMEN
        • C'EST LA VIE
        • MAGAZINE
        About us Contact usPrivacy PolicyTerms and ConditionsSitemap
        Copyright © 2019 Outlook Business!. All pages of the Website are subject to our terms and conditions and privacy policy. You must not reproduce, duplicate, copy, sell, resell or exploit any material on the Website for any commercial purposes.